Abstract
Many pathologies of the central nervous system (CNS) originate from excess of reactive free radicals, notably reactive oxygen species (ROS), and oxidative stress. A phenomenon which usually runs in parallel with oxidative stress is unsaturated lipid peroxidation, which, via a chain reaction, contributes to the progression of disbalanced redox homeostasis. Among long-chain (LC) polyunsaturated fatty acids (PUFAs) abundantly occurring in the CNS, docosahexaenoic acid (DHA), a member of ω-3 LC-PUFAs, deserves special attention, as it is avidly retained and uniquely concentrated in the nervous system, particularly in retinal photoreceptors and synaptic membranes; owing to the presence of the six double bonds between carbon atoms in its polyene chain (C=C), DHA is exquisitely sensitive to oxidative damage. In addition to oxidative stress and LC-PUFAs peroxidation, other stress-related mechanisms may also contribute to the development of various CNS malfunctions, and a good example of such mechanisms is the process of lipofuscin formation occurring particularly in the retina, an integral part of the CNS. The retinal lipofuscin is formed and accumulated by the retinal pigment epithelial (RPE) cells as a consequence of both visual process taking place in photoreceptor-RPE functional complex and metabolic insufficiency of RPE lysosomal compartment. Among various retinal lipofuscin constituents, bisretinoids, originating from all-trans retinal substrate — a photometabolite of visual pigment cofactor 11-cis-retinal (responsible for photon capturing), are endowed with cytotoxic and complement-activating potential which increases upon illumination and oxidation. This survey deals with oxidative stress, PUFAs (especially DHA) peroxidation products of carboxyalkylpyrrole type and bisretinoids as potential inducers of the CNS pathology. A focus is put on vision-threatening disease, i.e., age-related macular degeneration (AMD), as an example of the CNS disorder whose pathogenesis has strong background in both oxidative stress and lipid peroxidation products.
Similar content being viewed by others
Abbreviations
- A2E:
-
–N-retinylidene-N-retinylethanolamine
- AGE:
-
–advanced glycation endproduct
- ALA:
-
–α-linolenic acid
- AMD:
-
–age-related macular degeneration
- ARA:
-
–arachidonic acid
- AT-RAL:
-
–all-trans retinal
- AT-RvD:
-
–aspirin-triggered resolvin
- CAP:
-
–carboxyalkylpyrrole
- CEP:
-
–2-(ω-carb-oxyethyl)pyrrole
- CFH:
-
–complement factor H
- CHP:
-
–2-(ω-carboxyheptyl)pyrrole
- CNS:
-
–central nervous system
- CNV:
-
–choroidal neovascularization
- CPP:
-
–2-((ω-carboxypropyl)pyr-role
- DHA:
-
–docosahexaenoic acid
- DPA:
-
–docosapentaenoic acid
- EP:
-
–ethylpyrrole
- EPA:
-
–eicosapentaenoic acid
- FA:
-
–fatty acid
- GLA:
-
–γ-linoleic acid
- HHE:
-
–4-hydroxy-hexenal
- HNE:
-
–4-hydroxy-nonenal
- HOAA:
-
–hydroxy-ω-oxoalkenoic acid
- HODA:
-
–9-hydroxy-12-oxydec-10-enoic acid
- HOHA:
-
–4-hydroxy-7-oxyhept-5-enoic acid
- HOOA:
-
–5-hydroxy-8-oxyoct-6-enoic acid
- HSA:
-
–human serum albumin
- LA:
-
–linoleic acid
- MAC:
-
–membrane attack complex
- MDA:
-
–malondialdehyde
- POS:
-
–photoreceptor outer segment
- LC-PUFA:
-
–long-chain polyunsaturated fatty acid
- MSA:
-
–mouse serum albumin
- NPD1:
-
–neuroprotectin-1
- PP:
-
–pentylpyrrole
- PUFA:
-
–polyunsaturated fatty acid
- RAL:
-
–retinal
- REs:
-
–retinol esters
- RNS:
-
–reactive nitrogen species
- ROL:
-
–retinol
- ROS:
-
–reactive oxygen species
- RPE:
-
–retinal pigment epithelium
- RvD:
-
–resolvin D
- RvE:
-
–resolvin E
- SOD:
-
–superoxide dismutase
- TLR:
-
–toll-like receptor
- TNFα:
-
–tumor necrosis factor α
- VEGF:
-
–vascular endothelial growth factor
References
Alfadda AA, Sallam RM: Reactive oxygen species in health and disease. J Biomed Biotechnol, 2012, 2012:936486, doi: 10.1155/2012/936486.
Algvere PV, Marshall J, Seregard S: Age-related maculopathy and the impact of blue light hazard. Acta Ophthalmol Scand, 2006, 84, 4–15.
Alvarez RA, Aguirre GD, Acland GM, Anderson RE: Docosapentaenoic acid is converted to docosahexaenoic acid in the retinas of normal and prcd-affected minature poodle dogs. Invest Ophthalmol Vis Sci, 1994, 35, 402–408.
Anderson DH, Radeke MJ, Gallo NB, Chapin EA, Johnson PT, Curletti CR, Hancox LS et al.: The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog Retin Eye Res, 2010, 29, 95–112.
Bazan NG: Cell survival matters: docosahexaenoic acid signaling, neuroprotection and photoreceptors. Trends Neurosci, 2006, 29, 263–271.
Bazan NG: Neuroprotectin D1-mediated anti-inflammatory and survival signaling in stroke, retinal degenerations, and Alzheimer disease. J Lipid Res, 2009, 50, S400–S405.
Bazan NG, Molina MF, Gordon WC: Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer’s, and other neurodegenerative diseases. Annu Rev Nutr, 2011, 31, 321–351.
Beatty S, Koh H, Phil M, Henson D, Boulton M: The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol, 2000, 45, 115–134.
Bhutto I, Lutty G: Understanding age-related macular degeneration (AMD): relationships between the photoreceptor/retinal pigment epithelium/Bruch’s membrane/choriocapillaries complex. Mol Asp Med, 2012, 33, 295–317.
Bhandary B, Marahatta A, Kim HR, Chae HJ: An involvement of oxidative stress in endoplasmic reticulum stress and its associated diseases. Int J Mol Sci, 2012, 14, 343–356.
Cai J, Nelson KC, Wu M, Sternberg P, Jones DP: Oxidative damage and protection of the RPE. Prog Retin Eye Res, 2000, 19, 205–221.
Cai X, McGinnis JF: Oxidative stress: the Achilles’ heel of neurodegenerative diseases of the retina. Front Biosci, 2012, 17, 1976–1995.
Crabb JW, Miyagi M, Gu X, Shadrach K, West KA, Sakaguchi H, Kamei M et al.: Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci USA, 2002, 99, 14682–14687.
Del Rio LA: Peroxisomes as a cellular source of reactive nitrogen species signal molecules. Arch Biochem Biophys, 2011, 506, 1–11.
Dröge W: Free radicals in the physiological control of cell control. Physiol Rev, 2002, 82, 47–95.
Ebrahem Q, Renganathan K, Sears J, Vasanji A, Gu X, Lu L, Salomon RG et al.: Carboxyethylpyrrole oxidative protein modifications stimulate neovascularization: implications for age-related macular degeneration. Proc Natl Acad Sci USA, 2006, 103, 13480–13484.
EFSA Panel on Dietetic Products, Nutrition and Allergies: Scientific opinion on the tolerable upper intake level of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and docosapentaenoic acid (DPA). EFSA J, 2012, 10, 2815.
Evans TA, Siedlak SL, Lu L, Fu X, Wang Z, McGinnis WR, Fakhoury E et al.: The autistic phenotype exhibits a remarkably localized modification of brain protein by products of free radical-induced lipid oxidation. Am J Biotechnol Biochem, 2008, 4, 61–72.
Fossel M: Cells, Aging and Human Disease. Oxford University Press, New York, 2004, pp. 504.
Gaillard ER, Atherton SJ, Eldred G, Dillon J: Photophysical studies on human retinal lipofuscin. Photochem Photobiol, 1995, 61, 448–453.
Gu X, Meer SG, Miyagi M, Rayborn ME, Hollyfield JG, Crabb JW, Salomon RG: Carboxyethylpyrrole protein adducts and autoantibodies, biomarkers for age-related macular degeneration. J Biol Chem, 2003, 278, 42027–42035.
Gu X, Sun M, Gugiu B, Hazen S, Crabb JW, Salomon RG: Oxidatively truncated docosahexaenoate phospholipids: total synthesis, generation, and peptide adduction chemistry. J Org Chem, 2003, 68, 3749–3761.
Hageman GS, Luthert PJ, Chong NH, Johnson LV, Anderson DH, Mullins RF: An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch’s membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res, 2001, 20, 705–732.
Harman D: Aging — a theory based on free-radical and radiation-chemistry. J Gerontol, 1956, 11, 298–300.
Hollyfield JG, Bonilha VL, Rayborn ME, Yang X, Shadrach KG, Lu L, Ufret RL et al.: Oxidative damage-induced inflammation initiates age-related macular degeneration. Nat Med, 2008, 14, 194–198.
Hollyfield JG, Perez VL, Salomon RG: A hapten generated from an oxidation fragment of docosahexaenoic acid is sufficient to initiate age-related macular degeneration. Mol Neurobiol, 2010, 41, 290–298.
Hollyfield JG, Salomon RG, Crabb JW: Proteomic approaches to understanding age-related macular degeneration. Adv Exp Med Biol, 2003, 533, 83–89.
Hunter JJ, Morgan JIW, Merigan WH, Sliney DH, Sparrow JR, Williams DR: The susceptibility of the retina to photodamage from visible light. Prog Retin Eye Res, 2012, 31, 28–42.
Issa PC, Chong NV, Scholl HPN: The significance of the complement system for the pathogenesis of age-related macular degeneration — current evidence and translation into clinical application. Graefes Arch Clin Exp Ophthalmol, 2011, 249, 163–174.
Jang YP, Matsuda H, Itagaki Y, Nakanishi K, Sparrow JR: Characterization of peroxy-A2E and furan-A2E photooxidation products and detection in human and mouse retinal pigment epithelial cell lipofuscin. J Biol Chem, 2005, 280, 39732–39739.
Jarret SG, Boulton ME: Consequences of oxidative stress in age-related macular degeneration. Mol Aspects Med, 2012, 33, 399–417.
Kaur K, Salomon RG, O’Neil J, Hoff HF: (Carboxyalkyl)pyrroles in human plasma and oxidized low-density lipoproteins. Chem Res Toxicol, 1997, 10, 1387–1396.
Khandhadia S, Cipriani V, Yates JRW, Lotery AJ: Age-related macular degeneration and the complement system. Immunobiology, 2012, 217, 127–146.
Kijlstra A, Tian Y, Kelly ER, Berendschot TTJM: Lutein: more than just a filter for blue light. Prog Retin Eye Res, 2012, 31, 303–315.
Kim SR, Jang YP, Jockusch S, Fishkin NE, Turro NJ, Sparrow JR: The all-trans-retinal dimer series of lipofuscin pigments in retinal pigment epithelial cells in a recessive Stargardt disease model. Proc Natl Acad Sci USA, 2007, 104, 19273–19278.
Kinnunen K, Petrovski G, Moe MC, Berta A, Kaarniranta K: Molecular mechanisms of retinal pigment epithelium damage and development of age-related macular degeneration. Acta Ophthalmol, 2012, 90, 299–309.
Klettner A: Oxidative stress induced cellular signaling in RPE cells. Front Biosci (Schol Ed), 2012, 4, 392–411.
Krohne TU, Kaemmerer E, Holz FG, Kopitz J: Lipid peroxidation products reduce lysosomal protease activities in human retinal pigment epithelial cells via two different mechanisms of action. Exp Eye Res, 2010, 90, 261–266.
Lin PY, Huang SY, Su KP: A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression. Biol Psychiatry, 2010, 68, 140–147.
Liu A, Chang J, Lin Y, Shen Z, Bernstein PS: Longchain and very long-chain polyunsaturated fatty acids in ocular aging and age-related macular degeneration. J Lipid Res, 2010, 51, 3217–3229.
Lu L, Gu X, Hong L, Laird J, Jaffe K, Choi J, Crabb JW, Salomon RG: Synthesis and structural characterization of carboxyethylpyrrole-modified proteins: mediators of age-related macular degeneration. Bioorg Med Chem, 2009, 17, 7548–7561.
Lukiw WJ: Docosahexaenoic acid and amyloid-β peptide signaling in Alzheimer’s disease. World Rev Nutr Diet, 2009, 99, 55–70.
Malhotra JD, Kaufman RJ: Endoplasmic reticulum stress and oxidative stress: a vicious cycle or double-edged sword? Antioxid Redox Signal, 2007, 9, 2277–2293.
Mettu PS, Wielgus AR, Ong S, Cousins SW: Retinal pigment epithelium response to oxidant injury in the pathogenesis of early age-related macular degeneration. Mol Aspects Med, 2012, 33, 376–398.
Mukherjee PK, Chwala A, Loayza MS, Bazan NG: Docosanoids are multifunctional regulators of neuronal cell integrity and fate: significance in aging and disease. Prostaglandins Leukot Essent Fatty Acids (PLEFA), 2007, 77, 233–238.
Mukherjee PK, Marcheselli VL, Serhan CN, Bazan NG: Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc Natl Acad Sci USA, 2004, 101, 8491–8496.
Murdaugh LS, Mandal S, Dill AE, Dillon J, Simon JD, Gaillard ER: Compositional studies of human RPE lipofuscin: mechanmsms of molecular modifications. J Mass Spectrom, 2011, 46, 90–95.
Novo E, Parola M: Redox mechanisms in hepatic chronic wound healing and fibrogenesis. Fibrogenesis Tissue Repair, 2008, 1, 5.
Nowak JZ: Age-related macular degeneration (AMD): a critical appraisal of diet and dietary supplements as therapeutic modalities. Mil Pharm Med, 2012, 4, 1–16.
Nowak JZ: Age-related macular degeneration (AMD): pathogenesis and therapy. Pharmacol Rep, 2006, 58, 353–363.
Nowak JZ: Biosynthesis and characteristics of antiinflammatory proresolving derivatives of omega-3 and omega-6 polyunsaturated fatty acids. Mil Pharm Med, 2011, 3, 30–41.
Nowak JZ: Inflammation: course and role of PUFA-derived lipid mediators in the resolution of inflammatory reaction. Mil Pharm Med, 2011, 1, 20–30.
Nowak JZ: The isolated retina as a model of the CNS in pharmacology. Trends Pharmacol Sci, 1988, 9, 80–82.
Ozawa Y, Sasaki M, Takahashi N, Kamoshita M, Miyake S, Tsubota K: Neuroprotective effects of lutein in the retina. Curr Pharm Des, 2012, 18, 51–56.
Peet M: Omega-3 polyunsaturated fatty acids in the treatment of schizophrenia. Isr J Psychiaty Relat Sci, 2008, 45, 19–25.
Plafker SM, O’Mealey GB, Szweda LI: Mechanisms for countering oxidative stress and damage in retinal pigment epithelium. Int Rev Cell Mol Biol, 2012, 298, 135–177.
Querques G, Forte R, Souied EH: Retina and omega-3. J Nutr Metab, 2011, article ID 748361.
Roberts JE: Ocular phototoxicity. J Photochem Photobiol B, 2001, 64, 136–143.
Ross BM: Omega-3 polyunsaturated fatty acids and anxiety disorders. Prostaglandins Leukot Essent Fatty Acids, 2009, 81, 309–312.
Rozanowska M, Jarvis-Evans J, Korytowski W, Boulton ME, Burke JM, Sarna T: Blue light-induced reactivityof retinal age pigment. In vitro generation of oxygen-reactive species. J Biol Chem, 1995, 270, 18825–18830.
Rozanowska M, Pawlak A, Rozanowska B, Skumatz C, Zareba M, Boulton ME, Burke JM et al.: Age-related changes in the photoreactivity of retinal lipofuscin granules: role of chloroform-insoluble components. Invest Ophthalmol Vis Sci, 2004, 45, 1052–1060.
Salomon RG, Hong L, Hollyfield JG: Discovery of carboxyethylpyrroles (CEPs): critical insights into AMD, autism, cancer, and wound healing from basic research on the chemistry of oxidized phospholipids. Chem Res Toxicol, 2011, 24, 1803–1816.
Sayre LM, Sha W, Xu G, Kaur K, Nadkarni D, Subbanagounder G, Salomon RG: Immunochemical evidence supporting 2-pentylpyrrole formation on proteins exposed to 4-hydroxy-2-nonenal. Chem Res Toxicol, 1996, 9, 1194–1201.
Schutt F, Bergmann M, Holz FG, Dithmar S, Volcker HE, Kopitz J: Accumulation of A2E in mitochondrial membranes of cultured RPE cells. Graefe’s Arch Clin Exp Ophthalmol, 2007, 245, 391–398.
Schutt F, Davies S, Kopitz J, Holz FG, Boulton ME: Photodamage to human RPE cells by A2E, a retinoid component of lipofuscin. Invest Ophthalmol Vis Sci, 2000, 41, 2303–2308.
Serhan CN, Petasis NA: Resolvins and protectins in inflammation resolution. Chem Rev, 2011, 111, 5922–5943.
Shinohara M, Mirakaj V, Serhan CN: Functional metabolomics reveals novel active products in the DHA metabolome. Front Immunol, 2012, 3, 81.
Sparrow JR: Bisretinoids of RPE lipofuscin: trigger for complement activation in age-related macular degeneration. Adv Exp Med Biol, 2010, 703, 63–74.
Sparrow JR, Boulton M: RPE lipofuscin and its role in retinal photobiology. Exp Eye Res, 2005, 80, 595–606.
Sparrow JR, Gregory-Roberts E, Yamamoto K, Blonska A, Ghosh SK, Ueda K, Zhou J: The bisretinoids of retinal pigment epithelium. Prog Retin Eye Res, 2012, 31, 121–135.
Sparrow JR, Nakanishi K, Parish CA: The lipofuscin fluorofore A2E mediates blue light-induced damage to retinal pigmented epithelial cells. Invest Ophthalmol Vis Sci, 2000, 41, 1981–1989.
Tanito M, Brush RS, Elliott MH, Wicker LD, Henry KR, Anderson RE: High levels of retinal membrane docosahexaenoic acid increase susceptibility to stress-induced degradation. J Lipid Res, 2009, 50, 807–819.
Terman A, Gustafsson B, Brunk UT: Mitochondrial damage and intralysosomal degradation in cellular aging. Mol Asp Med, 2006, 27, 471–482.
Thurman JM, Renner B, Kunchihapautham K, Fereirra VP, Pangburn MK, Ablinczy Z, Tomlinson S et al.: Oxidative stress renders retinal pigment epithelial cells susceptible to complement-mediated injury. J Biol Chem, 2009, 284, 16939–16947.
Trouw LA, Daha MR: Role of complement in innate immunity and host defence. Immunol Lett, 2011, 138, 35–37.
Uchiki T, Weikel KA, Jiao W, Shang F, Caceres A, Pawlak D, Handa JT et al.: Glycation-altered proteolysis as a pathobiologic mechanism that links dietary glycemic index, aging, and age-related disease (in non-diabetics). Aging Cell, 2012, 11, 1–13.
Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M, Tesler J: Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol, 2007, 39, 44–84.
Wallace DC, Brown MD, Melov S, Graham B, Lott M: Mitochondrial biology, degenerative diseases and aging. Biofactors, 1998, 7, 187–190.
Wang N, Anderson RE: Enrichment of polyunsaturated fatty acids from rat retinal pigment epithelium to rod outer segments. Curr Eye Res, 1992, 11, 783–791.
West XZ, Malinin NL, Merkulova AA, Tischenko M, Kerr BA, Borden EC, Podrez EA et al.: Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands. Nature, 2010, 467, 972–976.
Wiktorowska-Owczarek A, Nowak JZ: Oxidative damage in age-related macular degeneration (AMD) and antioxidant protection as a therapeutic strategy. Pol J Environ Stud, 2006, 15, 69–72.
Wu Y, Yanase E, Feng X, Siegel MM, Sparrow JR: Structural characterization of bisretinoid A2E photocleavage products and implications for age-related macular degeneration. Proc Natl Acad Sci USA, 2010, 107, 7275–7280.
Xu H, Chen M, Forrester JV: Para-inflammation in the aging retina. Prog Retin Eye Res, 2009, 28, 348–368.
Yu DY, Cringle SJ: Retinal degeneration and local oxygen metabolism. Exp Eye Res, 2005, 80, 745–751.
Zhou J, Jang YP, Kim SR, Sparrow JR: Complement activation by photooxidation products of A2E, a lipofuscin constituent of the retinal pigment epithelium. Proc Natl Acad Sci USA, 2006, 103, 16182–16187.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nowak, J.Z. Oxidative stress, polyunsaturated fatty acids-derived oxidation products and bisretinoids as potential inducers of CNS diseases: focus on age-related macular degeneration. Pharmacol. Rep 65, 288–304 (2013). https://doi.org/10.1016/S1734-1140(13)71005-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1016/S1734-1140(13)71005-3